Laboratorios Farma | ROVI - Assets



Laboratorios Farma reported EUR869.6M in Assets for its fiscal semester ending in June of 2025.


Assets Change Date
Alaunos Therapeutics USD 2.76M 795K Dec/2024
Almirall EUR 2.31B 88.18M Jun/2025
Avita Medical AUD 79.71M 8.12M Dec/2024
Dianthus Therapeutics USD 326.08M 47.93M Jun/2025
Ionis Pharmaceuticals USD 2.99B 172.18M Jun/2025
IQVIA Holdings USD 28.63B 1.31B Jun/2025
Laboratorios Farma EUR 869.6M 37.58M Jun/2025
Moderna USD 12.01B 694M Jun/2025
Organon & Co USD 13.5B 344M Jun/2025
Pharma Mar EUR 348.25M 14.75M Jun/2025
Revvity USD 12.36B 2.06M Jun/2025
Tectonic Therapeutic USD 295.31M 142.4M Jun/2025
Viatris USD 38.41B 63.4M Jun/2025
Xeris Pharmaceuticals USD 334.69M 11.63M Jun/2025